FindTrial
Sign In

A study to find how common the Ayurvedic causes are and to document body types in women with abnormal uterine bleeding

Prevalence of Asrigdara Nidana and Prakriti Distribution in Patients with Asrigdara (Abnormal Uterine Bleeding): A Hospital-Based Cross-Sectional Observational Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/102001
Enrollment
135
Registered
2026-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

Meghna Viswanath
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women under the age group of 50 having the complaints of Asrigdara (AUB).

Exclusion criteria

Exclusion criteria: 1. Pregnancy or postpartum complications 2. Abortion within the last 6 months 3. Recent uterine surgery within last 6 months 4. Known autoimmune disorders

Design outcomes

Primary

MeasureTime frame
1. To identify the most prevalent Nidanas observed in patients with Asrigdara in the present clinical setting. 2. Document the distribution of Prakriti among women diagnosed with AsrigdaraTimepoint: At Baseline ( single assessment at the time of enrolment).—

Secondary

MeasureTime frame
To develop a comprehensive checklist for the Ayurvedic diagnosis of Asrigdara based on classical textual descriptions, and to subject it to face and content validation by domain experts.Timepoint: At baseline (during the study period)—

Countries

India

Contacts

Public ContactDr Rajitha R Warriar

Govt Ayurveda College Kannur

drrajithawarriar@gmail.com9947144562

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026